CY1120748T1 - Ανασυνδυασμενο μυκοβακτηριο ως εμβολιο για χρηση σε ανθρωπους - Google Patents

Ανασυνδυασμενο μυκοβακτηριο ως εμβολιο για χρηση σε ανθρωπους

Info

Publication number
CY1120748T1
CY1120748T1 CY181100918T CY181100918T CY1120748T1 CY 1120748 T1 CY1120748 T1 CY 1120748T1 CY 181100918 T CY181100918 T CY 181100918T CY 181100918 T CY181100918 T CY 181100918T CY 1120748 T1 CY1120748 T1 CY 1120748T1
Authority
CY
Cyprus
Prior art keywords
vaccine
recommendated
mycocacture
human use
relates
Prior art date
Application number
CY181100918T
Other languages
English (en)
Inventor
Leander Grode
Original Assignee
Vakzine Projekt Man Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vakzine Projekt Man Gmbh filed Critical Vakzine Projekt Man Gmbh
Publication of CY1120748T1 publication Critical patent/CY1120748T1/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/04Mycobacterium, e.g. Mycobacterium tuberculosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • A61P31/06Antibacterial agents for tuberculosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Η εφεύρεση σχετίζεται με ένα ανασυνδυασμένο εμβόλιο που παρέχει προστατευτική ανοσία ιδιαίτερα έναντι φυματίωσης σε ανθρώπινα υποκείμενα.
CY181100918T 2010-09-20 2018-09-04 Ανασυνδυασμενο μυκοβακτηριο ως εμβολιο για χρηση σε ανθρωπους CY1120748T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38437510P 2010-09-20 2010-09-20
PCT/EP2011/066131 WO2012038348A1 (en) 2010-09-20 2011-09-16 Recombinant mycobacterium as vaccine for use in humans

Publications (1)

Publication Number Publication Date
CY1120748T1 true CY1120748T1 (el) 2019-12-11

Family

ID=44645725

Family Applications (2)

Application Number Title Priority Date Filing Date
CY181100918T CY1120748T1 (el) 2010-09-20 2018-09-04 Ανασυνδυασμενο μυκοβακτηριο ως εμβολιο για χρηση σε ανθρωπους
CY20201100331T CY1123049T1 (el) 2010-09-20 2020-04-07 Ανασυνδυασμενο μυκοβακτηριο ως εμβολιο για χρηση σε ανθρωπους

Family Applications After (1)

Application Number Title Priority Date Filing Date
CY20201100331T CY1123049T1 (el) 2010-09-20 2020-04-07 Ανασυνδυασμενο μυκοβακτηριο ως εμβολιο για χρηση σε ανθρωπους

Country Status (26)

Country Link
US (1) US9084749B2 (el)
EP (2) EP2618837B1 (el)
JP (1) JP5919276B2 (el)
KR (1) KR101907222B1 (el)
CN (1) CN103118703A (el)
AU (1) AU2011304385B2 (el)
BR (1) BR112013006245A2 (el)
CA (1) CA2811158C (el)
CU (1) CU24182B1 (el)
CY (2) CY1120748T1 (el)
DK (2) DK2618837T3 (el)
EA (1) EA026661B1 (el)
ES (2) ES2685928T3 (el)
HK (1) HK1258603A1 (el)
HR (2) HRP20181387T1 (el)
HU (2) HUE039038T2 (el)
LT (2) LT2618837T (el)
MX (1) MX346708B (el)
PL (2) PL2618837T3 (el)
PT (2) PT2618837T (el)
RS (2) RS60146B1 (el)
SG (1) SG188595A1 (el)
SI (2) SI3360569T1 (el)
UA (1) UA112297C2 (el)
WO (1) WO2012038348A1 (el)
ZA (1) ZA201301187B (el)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX345575B (es) * 2010-12-21 2017-02-03 Max-Planck-Gesellschaft Zur Förderung Der Wss E V Micobacteria recombinante como vacuna.
EP3090757A1 (en) 2015-05-04 2016-11-09 Vakzine Projekt Management GmbH Recombinant mycobacterium as an immunotherapeutic agent for the treatment of cancer
KR102338845B1 (ko) 2020-05-22 2021-12-13 서울대학교산학협력단 플랩 구동 장치 및 회전익기의 블레이드

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5733151A (en) 1996-08-23 1998-03-31 Edsall; David Electrical clamping connection device
AUPO761697A0 (en) 1997-06-30 1997-07-24 Cardiac Crc Nominees Pty Limited Process for the purification of polyethers
EP0902086A1 (en) 1997-08-22 1999-03-17 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Tuberculosis vaccine
CN1513551A (zh) * 2002-09-09 2004-07-21 丛繁滋 复合生物制品组合物及其制备方法
WO2004094469A1 (en) * 2003-04-23 2004-11-04 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Tuberculosis vaccine with improved efficacy
EP1649869A1 (en) * 2004-10-21 2006-04-26 Vakzine Projekt Management GmbH Combination of a recombinant mycobacterium and a biologically active agent as a vaccine

Also Published As

Publication number Publication date
PT3360569T (pt) 2020-04-17
BR112013006245A2 (pt) 2016-06-07
PL3360569T3 (pl) 2020-07-27
ES2784451T3 (es) 2020-09-25
HK1258603A1 (zh) 2019-11-15
SG188595A1 (en) 2013-04-30
LT3360569T (lt) 2020-05-11
EA026661B1 (ru) 2017-05-31
KR20140017484A (ko) 2014-02-11
EA201300380A1 (ru) 2013-07-30
SI2618837T1 (sl) 2018-11-30
LT2618837T (lt) 2018-09-25
EP2618837A1 (en) 2013-07-31
CY1123049T1 (el) 2021-10-29
HUE039038T2 (hu) 2018-12-28
EP2618837B1 (en) 2018-08-08
CN103118703A (zh) 2013-05-22
CU20130041A7 (es) 2013-06-28
US9084749B2 (en) 2015-07-21
CU24182B1 (es) 2016-07-29
HUE048774T2 (hu) 2020-08-28
SI3360569T1 (sl) 2020-07-31
KR101907222B1 (ko) 2018-10-11
HRP20200610T1 (hr) 2020-10-02
ES2685928T3 (es) 2018-10-15
JP5919276B2 (ja) 2016-05-18
JP2013538225A (ja) 2013-10-10
MX346708B (es) 2017-03-29
MX2013002989A (es) 2013-10-17
AU2011304385A1 (en) 2013-03-21
DK3360569T3 (da) 2020-04-06
PT2618837T (pt) 2018-10-18
PL2618837T3 (pl) 2018-11-30
EP3360569A1 (en) 2018-08-15
AU2011304385B2 (en) 2015-02-26
ZA201301187B (en) 2013-09-25
US20130280287A1 (en) 2013-10-24
EP3360569B1 (en) 2020-03-18
CA2811158A1 (en) 2012-03-29
HRP20181387T1 (hr) 2018-11-02
WO2012038348A1 (en) 2012-03-29
CA2811158C (en) 2019-06-25
RS57574B1 (sr) 2018-11-30
DK2618837T3 (en) 2018-10-01
RS60146B1 (sr) 2020-05-29
UA112297C2 (uk) 2016-08-25

Similar Documents

Publication Publication Date Title
CY1124024T1 (el) Νεες ctla4-ig ανοσοπροσκολλητινες
CY1119586T1 (el) Ταπενταδολη για προληψη και θεραπεια καταθλιψης και αγχους
DK2940135T5 (da) Heterodimeriseret polypeptid
UY34411A (es) Inmunoenlazantes dirigidos contra esclerostina
CO7061035A2 (es) Péptido de tránsito al cloroplasto
DK2728002T3 (da) Heterodimeriseret polypeptid
BR112015006200A2 (pt) conjunto de braço de cadeira
DK2895509T3 (da) T-cellereceptorer, som genkender mhc-klasse ii begrænset mage-a3
UY34409A (es) Inmunoenlazadores dirigidos contra el tnf
BR112014033077A2 (pt) combinação de vacina.
CO7020893A2 (es) Conjunto de desgaste
CY1118539T1 (el) Ανασυνδυασμενο μυκοβακτηριο ως εμβολιο
MX2021004211A (es) Composiciones vacuna.
DK3281607T3 (da) Implanterbar protese med acellulære vævsvedhæftninger.
CO7061056A2 (es) Dispositivo para el cuidado bucal
BR112015012907A2 (pt) composição de cuidado pessoal
CY1123049T1 (el) Ανασυνδυασμενο μυκοβακτηριο ως εμβολιο για χρηση σε ανθρωπους
CY1121067T1 (el) Εμβολιο πεπτιδιου pcsk9
EA201590503A1 (ru) Альфа-1-микроглобулин для применения в лечении заболеваний, связанных с митохондриями
EA201390955A1 (ru) Слитый белок robo1-fc для применения в лечении гепатокарциномы
UY34286A (es) Diagnóstico de vacuna mejorado
IT1400227B1 (it) Molla di contatto per contatto di sicurezza e contatto di sicurezza comprendente tale molla
CY1119212T1 (el) Χρηση του odiparcil στη θεραπεια μιας μυκοπολυσακχαριδωσης
CY1117412T1 (el) Προσδιορισμος της αποτελεσματικοτητας ενος αντι-μυκοβακτηριακου εμβολιασμου
CY1117742T1 (el) Ταπενταδολη για χρησιμοποιηση στη θεραπεια συνδρομου ευερεθιστου εντερου